Sanofi Healthcare has led a $ 17 m investment in Click Therapeutics , which develops software to treat medical conditions such as depression , insomnia , acute coronary syndrome and chronic pain , via a mobile app prescribed by doctors . Click is seeking clearance from the US Food and Drug Administration ( FDA ) to sell the products as class A medical devices . Four pharma companies—Merck, Shire, Amgen, and Pfizer—have each aligned with Akili either via investments or partnerships. Last September , Pear Therapeutics received FDA approval for its reSET software , used to treat substance misuse , while Akili Game Labs is seeking FDA clearance for video games to assess and treat attention deficit hyperactivity disorder in children .
Sanofi Healthcare has led a $ 17 m investment in Click Therapeutics , which develops software to treat medical conditions such as depression , insomnia , acute coronary syndrome and chronic pain , via a mobile app prescribed by doctors . Click is seeking clearance from the US Food and Drug Administration ( FDA ) to sell the products as class A medical devices . Last September , Pear Therapeutics received FDA approval for its reSET software , used to treat substance misuse , while Akili Game Labs is seeking FDA clearance for video games to assess and treat attention deficit hyperactivity disorder in children .